Tag Archive for: Sohonos

FDA approves Ipsen’s palovarotene for ultra-rare bone disease

After two prior setbacks, the regulator has finally approved Ipsen’s palovarotene to treat fibrodysplasia ossificans progressiva. It’s the first treatment for the ultra-rare bone disease.

Read more
/by

Ipsen’s FOP saga continues as FDA postpones Oct. 31 adcom

,

Ipsen’s fibrodysplasia ossificans progressiva (FOP) odyssey continues as the FDA’s Endocrinologic and Metabolic Drugs Advisory Committee postponed its meeting on the NDA for palovarotene capsules.

Read more
/by